NFKB1 and B-cell chronic lymphocytic leukemia: For example, TLR-mediated production of TNFα by CLL cells can be inhibited by prior treatment with IL-6 and restored by a JAK inhibitor (34) and IL-4 can block NFκB at the DNA level (39).